CyBio AG: capital increase at a ratio of 8:1 to finance planned growth

Jena, (PresseBox) - the Management Board of CyBio AG, Jena, (German Stock Exchange: General Standard, ISIN-Number DE0005412308) today passed a resolution, with the approval of the Supervisory Board, to increase the company’s share capital for cash by 600.000 new bearer shares under utilization of the authorized capital. A subscription right is granted to the shareholders.
According to the resolved subscription ratio of 8:1, one new CyBio share may be subscribed for eight old shares at a subscription price of 4.00 EUR. A trading in subscription rights is excluded. The subscription period is expected to commence on 25th June 2007 and end on 9th of July 2007.
Shareholders unsubscribed shares will be placed with institutional investors for a subscription price of 4.00 EUR. The subscription will lead to proceeds of approximately 2.40 Mio. EUR. The influx of funds will strengthen CyBio’s equity base and provide the necessary flexibility to soundly finance the planned internal and external growth in the field of automation and the innovative new generation of instruments.

In the upcoming periods CyBio will focus its R & D activities on a new modular liquid handling system for the pharmaceutical industry.

The business year 2007 continues to develop within CyBio´s expectations. In comparison to last year CyBio is confident to achieve a significant increase in the mid-year turnover.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.